Published online before print November 1, 2004, doi: 10.1161/01.HYP.0000147893.08533.d8
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2004;44:847.)
© 2004 American Heart Association, Inc.
Scientific Contributions |
Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension
From the Department of Cardiology, St. James’s University Hospital, Leeds, United Kingdom.
Correspondence to Dr Robert J. Huggett, Department of Cardiology, St. James’s University Hospital, Beckett Street, Leeds LS9 7TF, United Kingdom. E-mail roberthuggett{at}hotmail.com
Hypertension is a major cardiovascular risk factor in the metabolic syndrome (MS) in which the presence of insulin resistance, glucose intolerance, abnormal lipoprotein metabolism, and central obesity all confer an increased risk. Because essential hypertension (EHT), insulinemia, and visceral fat are associated with sympathetic hyperactivity, which is itself known to increase cardiovascular risk, the aim of this study was to see if MS is a state of sympathetic nerve hyperactivity and if the additional presence of EHT intensifies this hyperactivity. In 69 closely matched subjects, comprising hypertensive MS (MS+EHT, 18), normotensive MS (MS-EHT, 17), hypertensives without MS (EHT, 16), and normotensive controls without MS (NC, 18), we measured resting muscle sympathetic nerve activity (MSNA) as assessed from multiunit discharges and from single units with defined vasoconstrictor properties (s-MSNA). The s-MSNA in MS+EHT (76±3.1 impulses/100 beats) was greater (at least P<0.01) than in MS-EHT (62±3.2 impulses/100 beats) and in EHT (60±2.3 impulses/100 beats), and all these were significantly greater (at least P<0.01) than in NC (46±2.7 impulse/100 beats). The multi-unit MSNA followed a similar trend. These findings suggest that MS is a state of sympathetic nerve hyperactivity and that the additional presence of hypertension further intensifies this hyperactivity. The degree of sympathetic hyperactivity seen in this study could be argued at least partly to contribute to the higher cardiovascular risk and metabolic abnormalities seen in MS+EHT patients.
Key Words: sympathetic nervous system • hypertension • metabolism
This article has been cited by other articles:
 |
|
 |
|
  C. Syme, M. Abrahamowicz, G. T. Leonard, M. Perron, L. Richer, S. Veillette, Y. Xiao, D. Gaudet, T. Paus, and Z. Pausova Sex Differences in Blood Pressure and Its Relationship to Body Composition and Metabolism in Adolescence Arch Pediatr Adolesc Med, September 1, 2009; 163(9): 818 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. E Straznicky, G. W Lambert, K. Masuo, T. Dawood, N. Eikelis, P. J Nestel, M. T McGrane, J. A Mariani, F. Socratous, R. Chopra, et al. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome Am. J. Clinical Nutrition, January 1, 2009; 89(1): 27 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Syme, M. Abrahamowicz, G. T. Leonard, M. Perron, A. Pitiot, X. Qiu, L. Richer, J. Totman, S. Veillette, Y. Xiao, et al. Intra-abdominal Adiposity and Individual Components of the Metabolic Syndrome in Adolescence: Sex Differences and Underlying Mechanisms Arch Pediatr Adolesc Med, May 1, 2008; 162(5): 453 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. B. Sverrisdottir, T. Mogren, J. Kataoka, P. O. Janson, and E. Stener-Victorin Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E576 - E581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lambert, N. Straznicky, M. Schlaich, M. Esler, T. Dawood, E. Hotchkin, and G. Lambert Differing Pattern of Sympathoexcitation in Normal-Weight and Obesity-Related Hypertension Hypertension, November 1, 2007; 50(5): 862 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Li, L. Wang, C.-W. Lee, T. A. Dawson, and D. J. Paterson Noradrenergic Cell Specific Gene Transfer With Neuronal Nitric Oxide Synthase Reduces Cardiac Sympathetic Neurotransmission in Hypertensive Rats Hypertension, July 1, 2007; 50(1): 69 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, F. Quarti-Trevano, F. Scopelliti, R. Dell'Oro, G. Bolla, and G. Mancia Excessive Sympathetic Activation in Heart Failure With Obesity and Metabolic Syndrome: Characteristics and Mechanisms Hypertension, March 1, 2007; 49(3): 535 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Mancia, M. Bombelli, G. Corrao, R. Facchetti, F. Madotto, C. Giannattasio, F. Q. Trevano, G. Grassi, A. Zanchetti, and R. Sega Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis Hypertension, January 1, 2007; 49(1): 40 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Guh, L.-Y. Chuang, and H.-C. Chen Betel-quid use is associated with the risk of the metabolic syndrome in adults Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1313 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H C Routledge and J N Townend Why does the heart rate response to exercise predict adverse cardiac events? Heart, May 1, 2006; 92(5): 577 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Petrova, R. Townsend, and K. L. Teff Prolonged (48-Hour) Modest Hyperinsulinemia Decreases Nocturnal Heart Rate Variability and Attenuates the Nocturnal Decrease in Blood Pressure in Lean, Normotensive Humans J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 851 - 859. [Abstract] [Full Text] [PDF]
|
|